Table 1. Correlation of CHRDL2 expression with clinicopathologic features in CRC tissues.
| Clinicopathologic features | Expression of CHRDL2 protein(IHC) | |||
|---|---|---|---|---|
| Total cases | High expression | Low expression | P values | |
| Age(years) | 0.911 | |||
| <60 | 76 | 38 | 38 | |
| ≥60 | 49 | 24 | 25 | |
| Gender | 0.792 | |||
| Female | 59 | 30 | 29 | |
| Male | 66 | 32 | 34 | |
| Tumor diameter(cm) | 0.009** | |||
| ≤5 | 71 | 28 | 43 | |
| >5 | 54 | 34 | 20 | |
| Tumor location | 0.858 | |||
| Colon | 69 | 35 | 34 | |
| Rectum | 56 | 27 | 29 | |
| Depth of infiltration | 0.385 | |||
| Submucosa, musculeris propria | 28 | 15 | 13 | |
| Subserosa | 66 | 29 | 37 | |
| To the surrounding tissue | 31 | 18 | 13 | |
| Histologic type | 0.023* | |||
| Well differentiated | 56 | 22 | 34 | |
| Morderately differentiated | 49 | 25 | 24 | |
| Poorly differentiated | 20 | 15 | 5 | |
| TNM staging | 0.002** | |||
| I/II | 81 | 32 | 49 | |
| III/IV | 44 | 30 | 14 | |
| Lymph node metastasis | 0.916 | |||
| YES | 45 | 26 | 19 | |
| NO | 80 | 47 | 33 | |
NOTE: p values were derived by using Chi-square test. (* p< 0.05. ** p< 0.01).